Consequently, intervention with an antibody to CD200 polarized CD2+MHC-II+CCR2+ myeloid precursors toward a proinflammatory phenotype in vitro and allowed the in vivo spreading of psoriatic disease from the skin to the joints even in initially arthritis-resistant mice. This evidence concerns the gene CCR2 and arthritic joint disease.